glp 1 bile acid malabsorption Glucagon-like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide, and Glucagon Receptor Agonists in Metabolic Dysfunction-Associated Steatotic Liver Disease: Novel Medication in New Liver Disease Nomenclature A Comprehensive Review of the

The question is no longer whether GLP-1 therapies will transform healthcare

GLP-1 and family history of thyroid cancer: Learn which thyroid cancer types contraindicate GLP-1 medications, understand FDA warnings about MTC and MEN 2, discover screening recommendations, and explore safe alternatives for high-risk patients.

Tara Narula breaks down new research suggesting GLP-1 medications may be linked to a lower risk of breast cancer diagnoses.

The attorneys want the cases handled by one federal court in Louisiana, and at least one manufacturer supports the effort

Study finds that a significant proportion of adults prescribed GLP-1 RAs for weight management discontinue treatment within a year